Implantable cardioverter-defibrillator (ICD) implantation belongs to the field of clinical cardiac electrophysiology. The procedure aims to prevent sudden cardiac death caused by dangerous ventricular heart rhythms. The device continuously monitors the electrical activity of the heart. When it detects abnormally fast or chaotic rhythms, it delivers low-energy pacing signals or high-energy electrical shocks to restore sinus rhythm.

The procedure is performed in an electrophysiology lab under local anesthesia and conscious sedation. A 4 to 7 centimeter incision is made below the left collarbone to form a subcutaneous pocket. A transvenous sheath is inserted into the subclavian or cephalic vein. Fluoroscopic X-ray guidance is used to advance thin leads into the right atrium, right ventricle, or coronary sinus depending on device type. Lead electrical parameters, including sensing, impedance, and pacing thresholds, are measured. Leads are connected to the pulse generator, which is placed inside the pocket. The incision is sutured in layers and dressed with a sterile bandage.

Evidence-based clinical benefits of ICD implantation include:

• Significant reduction in total mortality among high-risk cardiac patients (AHA/ACC/HRS Guidelines)
• Immediate, automated treatment of primary cardiac arrest without reliance on external emergency response timing
• Effective termination of sustained ventricular tachycardia through painless low-voltage pacing (anti-tachycardia pacing)
• Continuous 24/7 cardiac rhythm monitoring with remote telemetry reporting to clinical teams
• Improved long-term survival in patients with severe heart failure and reduced left ventricular ejection fraction

Immediate post-procedure care involves overnight hospital observation with cardiac telemetry monitoring. Pain at the incision site is typically mild to moderate and managed with analgesics. For the first 2 to 4 weeks, patients must restrict movements of the arm on the implanted side above shoulder level to prevent lead displacement. Driving is restricted according to clinical guidelines and local regulations, typically ranging from 1 week for primary prevention to 6 months following an arrhythmia event or shock delivery. Full healing of the surgical pocket occurs within 4 to 6 weeks, after which normal daily activities and low-impact exercise can resume.

ICD implantation is indicated for the treatment and management of:

• Sustained ventricular tachycardia (rapid heart rhythm originating in the lower heart chambers)
• Ventricular fibrillation (chaotic, disorganized electrical activity causing cardiac arrest)
• Ischemic cardiomyopathy with reduced ejection fraction (heart muscle damage following a heart attack)
• Non-ischemic dilated cardiomyopathy with severe left ventricular dysfunction
• Hypertrophic cardiomyopathy with high-risk features for sudden cardiac arrest
• Inherited arrhythmia syndromes, including Long QT Syndrome, Brugada Syndrome, and Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
• Prior survival of an unprovoked cardiac arrest

Pre-procedure evaluation includes a baseline 12-lead electrocardiogram, baseline blood work (kidney function, electrolytes, blood counts), and an echocardiogram to assess ejection fraction. Anticoagulants and antiplatelet medications may be temporarily adjusted under clinical guidance. Patients fast from solid food and liquids for 6 to 8 hours prior to the procedure. Preoperative antibiotic prophylaxis is administered intravenously within one hour of incision to minimize infection risk.

Minor and common complications include localized bruising, mild pain, and minor hematoma at the incision site. Major complications occur in less than 2-3% of cases and include lead dislodgement, surgical site or device pocket infection, pneumothorax (collapsed lung), cardiac perforation, hemothorax, and inappropriate shocks due to rhythm misinterpretation or lead malfunction.

The clinical journey for ICD implantation begins with an electrophysiology evaluation, including electrocardiograms, echocardiograms, and blood tests to confirm indication. On the day of the procedure, local anesthesia and conscious sedation are administered. A small surgical pocket is created below the collarbone, and thin insulated wires are guided through a vein into the heart chambers under fluoroscopic imaging. The leads are connected to the pulse generator, which is inserted into the pocket, and the incision is closed. Patients typically stay overnight for continuous telemetry monitoring. Early recovery involves restricted arm movement and wound care for 2 to 4 weeks, followed by long-term remote device monitoring and periodic clinical follow-ups.